Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
ACS Nano|December 12, 2013
Enhanced lifetime of excitons in nonepitaxial Au/CdS core/shell nanocrystalsScott Lambright, Evgeniia Butaeva, Natalia Razgoniaeva, et al.
Scientific Reports|May 18, 2021
Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cellsPratim Chowdhury, Dimuthu Perera, Reid T Powell, et al.
Cytokine|September 13, 2022
Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymusMaria M Szwarc, Lan Hai, Vineet K Maurya, et al.
Nature Communications|September 7, 2021
Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcinHua Mao, Luge Li, Qiying Fan, et al.
Cancer Medicine|June 9, 2022
Integrative metabolomics and transcriptomics analysis reveals novel therapeutic vulnerabilities in lung cancerJose Thaiparambil, Jianrong Dong, Sandra L Grimm, et al.
Diabetes|July 14, 2018
miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in ObesityEun-Hee Koh, Natasha Chernis, Pradip K Saha, et al.
Leukemia|March 3, 2021
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphomaWarren Fiskus, Christopher P Mill, Dimuthu Perera, et al.
Blood Cancer Journal|January 17, 2019
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cellsWarren Fiskus, Tianyu Cai, Courtney D DiNardo, et al.
Oncotarget|July 15, 2021
Esomeprazole enhances the effect of ionizing radiation to improve tumor controlKassidy A Hebert, Sergio Jaramillo, Wangjie Yu, et al.
Blood|April 27, 2019
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 3